Liontrust Investment Partners’s Merck MRK Stock Holding History

Liontrust Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,660	Closed	-$508K	–	213
2025 Q1	$508K	Sell	5,660 -5,506	-49%	-$514K	0.01%	190
2024 Q4	$1.11M	Sell	11,166 -64,773	-85%	-$6.68M	0.02%	168
2024 Q3	$9.4M	Hold	75,939	–	–	0.13%	97
2024 Q2	$9.4M	Sell	75,939 -20,198	-21%	-$2.6M	0.13%	97
2024 Q1	$12.7M	Sell	96,137 -11,625	-11%	-$1.43M	0.18%	89
2023 Q4	$11.7M	Sell	107,762 -4,592	-4%	-$477K	0.17%	92
2023 Q3	$11.6M	Buy	112,354 +84,482	+303%	+$9.11M	0.18%	81
2023 Q2	$3.22M	Sell	27,872 -3,680	-12%	-$418K	0.05%	165
2023 Q1	$3.36M	Buy	+31,552	New	+$3.41M	0.05%	153
2022 Q4	–	Sell	-79,387	Closed	-$6.84M	–	225
2022 Q3	$6.84M	Sell	79,387 -3,700	-4%	-$330K	0.11%	106
2022 Q2	$7.58M	Buy	+83,087	New	+$7.37M	0.11%	118
2021 Q4	–	Sell	-6,040	Closed	-$454K	–	224
2021 Q3	$454K	Buy	+6,040	New	+$459K	0.01%	219
2020 Q4	$2.53M	Buy	+32,425	New	+$2.48M	0.05%	136

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Liontrust Investment Partners's MRK Position: Q2 2025 in Review

Liontrust Investment Partners sold out of Merck (MRK) in Q2 2025, closing a stake of 5,660 shares — an estimated $508K sold.

Liontrust Investment Partners first reported a position in MRK in Q4 2020 and held it in 13 quarters. The position peaked at $12.7M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

Liontrust Investment Partners reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
Liontrust Investment Partners sold 5,660 Merck shares in Q2 2025, an estimated $508K.
Liontrust Investment Partners first reported a position in Merck in Q4 2020 and held it in 13 quarters.
Liontrust Investment Partners's Merck position peaked at $12.7M in Q1 2024.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Liontrust Investment Partners's 13F filing for Q2 2025, filed 19 Aug 2025.